<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The present study was aimed at clarifying the expression of ubiquitin carboxyl-terminal hydrolase 22 (USP22), a novel deubiquitinating enzyme gene, in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and its clinical significance </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: USP22 expression was detected with quantitative RT-PCR, Western blot, and immunohistochemistry (IHC) in 43 CRCs and non-cancerous matched tissues </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, USP22 protein expression was analyzed in 192 CRC <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> by IHC to evaluate the association with survival </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In 43 paired fresh tissues, the expression level of USP22 was significantly higher in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> than that in the paired non-cancerous tissues at both <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels (P &lt; 0.0001) </plain></SENT>
<SENT sid="4" pm="."><plain>Nuclear USP22 expression significantly increased from <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa through <z:mpath ids='MPATH_270'>adenoma</z:mpath> to primary <z:mp ids='MP_0002038'>carcinoma</z:mp> (P &lt; 0.0001) and from primary <z:mp ids='MP_0002038'>carcinoma</z:mp> to <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (P = 0.021) </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of positive USP22 expression was 54.16% in 192 conventional <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues </plain></SENT>
<SENT sid="6" pm="."><plain>Notably, high USP22 expression was significantly associated with shorter disease-specific survival (P &lt; 0.0001) and shorter disease-free survival (P &lt; 0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>Cox regression analysis showed USP22 was an independent prognostic parameter for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: USP22 might be an independent predictive factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> prognosis and aberrant expression of USP22 may play an essential role in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
</text></document>